Comparison of Regorafenib, Fruquintinib, and TAS-102 in Previously Treated Patients with Metastatic Colorectal Cancer: A Systematic Review and Network Meta-Analysis of Five Clinical Trials

BACKGROUND: This study aimed to conduct a systematic review of the literature to identify key randomized controlled clinical trials (RCTs), followed by network meta-analysis, to compare the efficacy and safety profiles of regorafenib, fruquintinib, and TAS-102 in previously treated patients with met...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jianxin, Wang, Junhui, Lin, Hai, Peng, Yonghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909918/
https://www.ncbi.nlm.nih.gov/pubmed/31790382
http://dx.doi.org/10.12659/MSM.918411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909918/
https://www.ncbi.nlm.nih.gov/pubmed/31790382
http://dx.doi.org/10.12659/MSM.918411

Ejemplares similares